A recall of one lot of Recombivax HB hepatitis B vaccine adult formulation by Merck Sharp & Dohme Corp due to the potential for a limited number of cracked vials. ... The Abbott RealTime HCV Genotype II, the first test that identifies the genotype of
According to ACP Member Aaron M. Harris, MD, MPH, of the division of viral hepatitis at the CDC, research suggests that while prescribers are generally familiar with clinical practice guideline recommendations
This issue covers patients who record physician visits, early interventions for hepatitis B, and the use of standardized patients in medical education. ... Earlier intervention for hepatitis B virus (HBV) infection is vitally important but doesn't happen
Other drugs that he urged cautious enthusiasm about included telaprevir and boceprevir, FDA-approved for hepatitis C virus (HCV) last year. ... Knight. It's too early to guess the price on RG7128, a hepatitis C drug that doesn't even have a name yet, but
Tenofovir disoproxil fumarate (Viread) for chronic hepatitis B in adults, with a recommended daily dose of 300 mg. ... Patients who discontinue Viread should be monitored closely for several months, as acute exacerbations of hepatitis have occurred in
Daclatasvir (Daklinza) for use with sofosbuvir to treat hepatitis C virus (HCV) genotype 3 infections.
Once an untreatable disease, hepatitis C is now coming close to being curable thanks to important new advances in therapy. ... But while new hepatitis C cases are on the decline in the U.S., the number of long-term cases is increasing.
Finally, this issue also includes two articles on combating hepatitis. The first gives an overview of a recently launched federal initiative that targets primary care physicians as vital partners in fighting ... Begun to improve care for patients with
More severe disorders can cause loss of brain cells in the frontal cortex and hippocampus, increased incidence of cancer and lung disease, and alcoholic hepatitis, said George Koob, PhD, director of
Simeprevir (Olysio), to treat chronic hepatitis C virus infection. A protease inhibitor, it is to be used as a component of combination antiviral treatment in adults with compensated liver disease, including